Clinical updates, including trial initiations, enrollment status and data readouts and publications: Draper, Rewalk, Viewray.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: ABM, Achilles, Bioinvent, Fibrogen, Kadmon, Myovant, Oncolytics, Oppilan, Principio, Reneo, Seelos, Sunesis, Vaccitech.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Beyond Air, Caredx, Guardant Health, Phase Scientific, Teleflex.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Arcutis, Aridis, Aurinia, Evelo, FSD, Heat, Hookipa, Janssen, Merck, Myokardia, Onconova, Pfizer, Revolution, Springworks, Tarsius, Ziopharm.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aurinia, Azevan, Boehringer, Clover, Cohbar, Cyclerion, Cymabay, Finch, Genentech, Lilly, Nkamerica, Novartis, Novo, Otsuka, Reistone, Ridgeback, Sanofi, Uniqure.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Livongo.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Affiris, Aptinyx, Aribio, Eloxx, Genentech, Heat, Hua, Innovent, Lineage Cell, Pfizer, Sangamo, Seattle Genetics, Teva, Xeris.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Affimed, Akero, Ascentage, Ascletis, Astrazeneca, Atara, Biomarin, Biosig, Cara, Contrafect, Dare, Dynavax, Evgen, Inflarx, Kiniksa, Lilly, Merck, Nantpharma, Recordati, Remegen, Sagimet.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Affibody, Amylyx, Applied Therapeutics, Ardelyx, Atyr, Bayer, Beyondspring, Cardiff Oncology, Catalyst, Genentech, Glycomimetics, Humanigen, Immunic, Immunicum, Inventiva, Iveric, Kyowa Kirin, Lilly, Lundbeck, Momenta, Navidea, Oncimmune, Phathom, PTC, Roche, Sinovac, Solasia, Tarsus.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Atyr, Can-Fite, Eli Lilly, Humanigen, Immunic, Kyowa Kirin, Moderna, Neurorx, Oncoimmune, Opko Health, Opthea, Orpheris, Otsuka, Pluristem, Regeneron, Relief, Sinovac, Solasia, Tychan.